mTOR Inhibitors in Children: Current Indications and Future Directions in Neurology

Keyphrases

• Neurology 100%
• MTOR Inhibitor 100%
• Mammalian Target of Rapamycin (mTOR) 80%
• Tuberous Sclerosis Complex 60%
• Target of Rapamycin Pathway 60%
• Treatment Options 20%
• Overactivation 20%
• Neurodegenerative Diseases 20%
• Cognitive Impairment 20%
• Genetic Disease 20%
• Rapamycin 20%
• Pediatric Population 20%
• Neurological Diseases 20%
• Targeted Treatment 20%
• Autism Spectrum Disorder 20%
• Potential Therapeutics 20%
• Pharmacological Therapy 20%
• Systemic Manifestations 20%
• Genetic Epilepsy 20%
• Epilepsy Syndrome 20%
• Safety Considerations 20%
• Therapeutic Applications 20%
• Neurodegenerative Conditions 20%
• Key Signaling Pathways 20%
• Approved Indications 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Mammalian Target of Rapamycin 100%
• Tuberous Sclerosis 33%
• Genetic Disorder 11%
• Syndrome 11%
• Rapamycin 11%
• Cognitive Defect 11%
• Degenerative Disease 11%
• Epilepsy 11%
• Diseases 11%
• Autism 11%